Table 4.
Multivariate analysis of factors associated with hazardous alcohol use (compared to moderate or none) among individuals on highly active antiretroviral therapy (n = 641)
| Variable | Multivariate OR (95% CI) |
|---|---|
| Sex | |
| Female | 1.0 (Ref) |
| Male | 1.55 (0.78–3.11) |
| Race/ethnicity | |
| White | 1.0 (Ref) |
| African American | 0.48 (0.23–1.00) |
| Hispanic | 1.92 (0.82–4.48) |
| Other | 0.27 (0.03–2.29) |
| Insurance | |
| Private | 1.0 (Ref) |
| Medicaid | 1.42 (0.60–3.38) |
| Medicare | 1.14 (0.37–3.48) |
| Medicaid/Medicare | 1.24 (0.51–3.00) |
| None | 2.96 (1.10–7.94)* |
| CD4 nadir (cells/μL) | |
| < 50 | 1.0 (Ref) |
| 50–199 | 1.70 (0.84–3.44) |
| 200–499 | 1.71 (0.80–3.64) |
| ≥ 500 | 1.76 (0.60–5.15) |
| Missing | 2.82 (0.81–9.80) |
| Adherence | |
| < 95% | 1.0 (Ref) |
| ≥ 95% | 0.49 (0.28–0.85)* |
| Illicit drug use | |
| Never | 1.0 (Ref) |
| Former | 1.64 (0.76–3.57) |
| Current | 2.61 (1.25–5.47)* |
| Primary care visits | |
| ≤ 3 visits | 1.0 (Ref) |
| 4–5 visits | 0.80 (0.36–1.80) |
| 6–7 visits | 0.93 (0.45–1.90) |
| ≥ 8 visits | 0.32 (0.14–0.75)* |
Multivariate analysis includes only those covariates with P < 0.20 in bivariate analysis. Analysis adjusted for site CI, confidence interval; OR, odds ratio.
P < 0.05.